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■ LETTER TO THE EDITOR ■
Posterior reversible encephalopathy syndrome (PRES)
is a neurologic disorder that affects the occipital lobe and
posterior parietal lobes of the brain. In 1996, Hinchey
et al first described the syndrome, which is manifested
clinically by headache, nausea and vomiting, seizures,
visual disturbance, and altered sensorium [1]. It is most
commonly associated with a number of clinical condi-
tions, including malignant hypertension, toxemic states
of pregnancy and use of immunosuppressive agents. 
A case of PRES occurring in a pregnant woman with
no history of preeclampsia is presented. The clinical
course, pathophysiology and imaging features of PRES
are discussed.
A 30-year-old primigravida had an isolated inci-
dence of elevated blood pressure (140/90mmHg), which
was measured twice with an interval of 4 hours, during
her prenatal check-up at 35 weeks of gestation. Mild
proteinuria (+1) was also observed. Ultrasonography
revealed oligohydramnios (amniotic fluid index, 5 cm).
The patient returned to the hospital at 37 and 38 weeks
of gestation and had blood pressure readings within the
normal range and an amniotic fluid index of 4 cm. The
fetus had an estimated weight within the 10th percentile
for gestational age. Persistent oligohydramnios prompted
hospitalization for labor induction at 39 weeks. Blood
pressure upon admission was 124/80 mmHg. Twelve
hours after admission, the patient complained of severe
headache. She had no known history of migraine head-
aches or seizures. Severe headache was then followed
by generalized tonic–clonic seizure. Her blood pressure
was 150/110 mmHg. The patient was treated with intra-
venous diazepam (10 mg), hydralazine (10 mg), and
magnesium sulfate (2 g). She underwent emergency
cesarean section. Placental abruption of more than
one-half of the placenta was noted during surgery.
Bloody amniotic fluid was also apparent. A 2,500-g
female neonate was delivered with 1- and 5-minute Apgar
scores of 7 and 8, respectively. Perioperative labora-
tory studies showed: proteinuria 1+, aspartate amino-
transferase 31 U/L, alanine aminotransferase 30 U/L,
lactate dehydrogenase 220 U/L, blood urea nitrogen
10 mg/dL, creatinine 1.0 g/dL, and platelet count
200,000 × 109/L.
The following day, the patient regained conscious-
ness but complained of mild headache and blurred
vision. Her blood cell count and electrolyte levels were
normal. Cerebrospinal fluid analysis revealed a protein
level of 44 mg/dL (normal range, 20–45 mg/dL), glu-
cose level of 67 mg/dL (normal range, 50–80 mg/dL),
and white blood cell count of 1/mm3 (normal level,
< 6/mm3). Cerebrospinal fluid culture, throat smear,
and blood and urine cultures were negative.
Her neurologic examination showed mild papill-
edema. Ophthalmologic examination showed best-
corrected visual acuity on the Snellen chart of 20/100
in each eye. Compared with someone with no visual
acuity impairment (having 20/20 vision on the Snellen
chart), an image 20 feet away has to be enlarged five
times to be recognized by a person with 20/100 visual
acuity. Color vision was normal. Photomotor reflex was
present in both eyes, and there was no evidence of
afferent pupillary defect. Visual field testing revealed no
visual field defects, but the foveal thresholds were clearly
reduced, which indicated that the foveae could see only
spots of high luminous intensity. Intraocular pressure
and slit-lamp examination were normal. Conjunctivitis
of both eyes was also diagnosed. Examination of other
cranial nerves, both motor and sensory, was normal.
However, there were increased tone and exaggerated
deep tendon reflexes.
Electroencephalogram showed intermittent gener-
alized slow activity. Initial magnet resonance imaging
(MRI) of the brain was performed 2 days after the ictus.
During this examination, bilateral hyperintense areas
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symmetrically located within the occipital region were
best demonstrated on coronal T2-weighted images
and fluid attenuated inversion recovery (FLAIR) images
(Figure).
Her blood pressure was controlled with intravenous
labetalol. Seizure prophylaxis (magnesium sulfate) was
continued for 48 hours. Her average blood pressure
was 130/80 mmHg.
On the seventh day after delivery, the patient was 
discharged seizure-free, with blood pressure of 120/
72 mmHg and markedly improved vision. Repeat MRI,
including FLAIR, and electroencephalogram 4 weeks
after discharge were unremarkable.
PRES is a recently recognized clinicoradiologic entity
characterized by headache, confusion, seizure, abnor-
malities in visual perception, diminished spontaneity of
speech, and altered consciousness [2,3]. Neuroimaging
at the height of symptoms shows diffuse edema predom-
inantly of the white matter, which selectively involves
the parieto-occipital regions of the brain [4,5].
Hypertensive encephalopathy, toxemia of pregnancy,
cyclosporin A toxicity, and uremic encephalopathy are
the most common causes of PRES [1,2,4,5–7]. However,
more recently, it has been related to pregnancy [8].
Cerebral MRI is the most appropriate method to demon-
strate central nervous system abnormalities. MRI FLAIR
is more sensitive than standard MRI [4,6]. Typical MRI
findings are hyperintense results on T2-weighted imaging
and hypointense results on T1-weighted imaging, reflect-
ing cerebral edema [1,2,4,5,9–11]. With MRI FLAIR, the
cortical parenchymal lesions are much better demon-
strated because of suppression of the cerebrospinal
fluid signal.
An important characteristic of PRES is the reversibil-
ity of the imaging abnormalities within days after appro-
priate therapy. However, if appropriate management is
delayed (such as the initiation of antihypertensive treat-
ment or discontinuation of immunosuppressive drugs),
there is a high risk of permanent neurologic damage
secondary to cerebral infarction or hemorrhages [4].
Essentially, the diagnosis of PRES is retrospective.
Significant reversal of neuroradiologic abnormalities,
along with complete clinical recovery, is suggestive of the
diagnosis. As in this case, PRES became apparent only
when the patient dramatically improved with antihy-
pertensive and anticonvulsant therapy.
MRI played a decisive role in the diagnosis of PRES,
since the patient presented with significant radiologic
improvement within a short time. In a study performed
by Pande et al, it was concluded that PRES due to
eclampsia showed maximal reversibility compared with
hypertension and drug-related PRES [5].
The pathophysiology of PRES has been a source 
of extensive debate among many investigators.
Hypertension-induced uncontrolled vasospasm, cou-
pled with autoregulatory failure, leads to hyperfusion
and extravasation of fluid into the brain parenchyma
because of breakdown of the blood–brain barrier [2,12].
This leakage of fluid from the vasculature is referred to
as “vasogenic edema” [12]. An immunosuppressive drug,
such as cyclosporin, causes vasculopathy and toxic effects
on vascular endothelial cells [3]. The vulnerability of
the posterior cerebral circulation compared with the
anterior brain circulation may be related to differences
in autonomic innervations. Sympathetically mediated
vasoconstriction protects the anterior circulation from
over-perfusion during acute hypertension and vaso-
spasms secondary to sudden and severe increases in
blood pressure or brain ischemia.
Notable in this case were the seizure and blurring of
vision being the only major neurologic manifestations
of encephalopathy. Also of interest in this patient was
the moderate acute elevation in blood pressure (150/
110 mmHg) that was documented during the ictus.
There was no dramatic blood pressure increase that typ-
ifies hypertensive encephalopathy. Moreover, the patient
had only one episode of elevated blood pressure (at 
35 weeks of gestation). In 1996, Schwartz reported a
case of PRES without hypertensive complications [13].
It has been proposed that the fluid accumulation
often observed during pregnancy, particularly in the third
trimester, may accentuate the increase in development of
vascular endothelial permeability in the brain [2]. Con-
sequently, an increase in permeability can be promoted
under hypertension. Brain edema, on the other hand,
might arise without difficulty in the state of eclampsia.
Figure. Fluid attenuated inversion recovery axial image
showing hyperintensity involving the cortex of the bilateral
occipital areas.
Taiwan J Obstet Gynecol • March 2008 • Vol 47 • No 1100
M.L. Ko, et al
With appropriate therapy, the prognosis of PRES is
excellent despite brain lesions. A clinician should, there-
fore, be aware of this syndrome, because early recog-
nition can lead to pertinent management and, once
prompt treatment is administered, the edematous pro-
cess can be immediately reversed before it progresses
to cause permanent brain injury.
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